Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Sustainable Development

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.

Development of the Lymphatic System

Development of the Lymphatic System

The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...

Language Development

Language Development

Children master language quickly and with relative ease, supported by both biological predisposition and reinforcement. B. F. Skinner (1957) proposed that language is learned through reinforcement, while Noam Chomsky (1965) argued that language acquisition mechanisms are biologically determined.
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...

Development of the Heart

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Accelerating development of vaccines for prevention and control of Alzheimer's disease.

Vaccine·2025

Same author

AI and the future of vaccine development.

Vaccine·2024

Same author

Historical Advances in Structural and Molecular Biology and How They Impacted Vaccine Development.

Journal of molecular biology·2023

Same author

Machine Learning-Based Single Cell and Integrative Analysis Reveals That Baseline mDC Predisposition Correlates With Hepatitis B Vaccine Antibody Response.

Frontiers in immunology·2021

Same author

Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.

European journal of epidemiology·2021

Same author

A universal coronavirus vaccine.

Science (New York, N.Y.)·2021

Search research articles

Related Experiment Video

Updated: Jan 20, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

The future of vaccine development.

Wayne C Koff¹, Theodore Schenkelberg¹

¹Human Vaccines Project, One Penn Plaza, Suite 6178, New York, NY 10119, United States.

|August 25, 2019

Summary

Developing new vaccines is challenging and costly, with low success rates for complex diseases and non-communicable conditions. Improvements are urgently needed to enhance vaccine effectiveness and streamline development processes.

Area of Science:

Immunology
Public Health
Biotechnology

Background:

Vaccines are highly successful public health tools, eradicating smallpox and reducing polio incidence.
Current vaccine development faces challenges with complex infectious diseases and non-communicable diseases like cancer.
Existing vaccine development is slow, expensive, and has a low success rate, with variable efficacy in vulnerable populations.

Purpose of the Study:

To highlight the limitations of current vaccine development.
To emphasize the need for improved vaccine effectiveness.
To call for advancements in vaccine development processes.

Main Methods:

Review of historical vaccine successes and failures.
Analysis of challenges in developing vaccines for complex diseases.

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Related Experiment Videos

Last Updated: Jan 20, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Examination of the economic and temporal costs of vaccine development.

Main Results:

Vaccines have eradicated smallpox and nearly eradicated polio.
Vaccine development is largely unsuccessful against cancer, autoimmunity, and neurodegenerative diseases.
The vaccine development process is costly, time-consuming, and has a success rate below 10%.

Conclusions:

There is a critical need to improve vaccine effectiveness.
Advancements are required to accelerate and enhance the vaccine development pipeline.
Future research should focus on overcoming obstacles in vaccine design and delivery for broader efficacy.